Abstract
A groundbreaking nanotechnology is promised by the exosome application in brain disorder treatments due to its phenomenal characteristic of being able to cross the blood-brain barrier (BBB), along with greater biocompatibility, low immunogenicity, and minimal side effects. Exosomes are involved in intracellular communication as they are noted to be heterogeneous group of nanoscale membrane-bound vesicles, typically 50–100 nm in diameter, secreted by both prokaryotic and eukaryotic cells. Their role seemed merely unimportant for years, until the last two decades, when their structure, role, and contents were studied and found that this paracrine cell-to-cell communication is achieved by substances carried in cargos, including interleukins and cytokines. Recent trend of investigations displayed how exosomes can come in handy in the pathogenesis, diagnosis, and treatment of several brain disorders, including Alzheimer’s disease, Parkinson’s disease, ischemic stroke, and many more, due to its natural ability to load both hydrophilic and hydrophobic compounds while crossing BBB. Currently, RMT (receptor-mediated transcytosis) of exosome is the prominent method of application, where ligands are expressed, such as LDLR-targeting apolipoprotein B, as engineered exosomes demonstrate much efficient drug uptake to the brain parenchyma. As comprehensive treatments of neurological disorders are currently in progress, it is crucial to comprehend the nature and potential of these exosomes; thus, radiolabeled exosomes can provide noninvasive tracking in understanding their activity in action, by imaging signal tissue penetration and accurate quantification. As per the recent studies, radiolabeled exosomes displayed higher sensitivity, specificity, and versatility while being noninvasive. This chapter will explore this nano-drug delivery system, exosome isolation by innovative means, and their physiochemical properties and will focus on the latest progression of radiolabeled exosomes technology underlying its BBB crossing ability, by summarizing natural, engineered, and radiolabeled assisted brain-targeted exosome-oriented drug treatment. We expect this chapter to also make our readers with major challenges in terms of exosome kinetics and clinical applications.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ahmad A (2022) Exosomes in cancer diagnosis and therapy. Int J Mol Sci 23:9930. https://doi.org/10.3390/IJMS23179930
Akbar A, Malekian F, Baghban N et al (2022) Methodologies to isolate and purify clinical grade extracellular vesicles for medical applications. Cell 11. https://doi.org/10.3390/CELLS11020186
Albers GW, Marks MP, Kemp S et al (2018) Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med 378:708. https://doi.org/10.1056/NEJMOA1713973
Almeida S, Santos L, Falcão A et al (2020) In vivo tracking of extracellular vesicles by nuclear imaging: advances in radiolabeling strategies. Int J Mol Sci 21:9443. https://doi.org/10.3390/IJMS21249443
Alvarez ML, Khosroheidari M, Kanchi Ravi R, Distefano JK (2012) Comparison of protein, microRNA, and mRNA yields using different methods of urinary exosome isolation for the discovery of kidney disease biomarkers. Kidney Int 82:1024–1032. https://doi.org/10.1038/ki.2012.256
Alzahrani FA, Saadeldin IM (2020) Role of exosomes in biological communication systems. Role Exosomes Biol Commun Syst:1–373. https://doi.org/10.1007/978-981-15-6599-1/COVER
An Y, Zhao J, Nie F et al (2019) Exosomes from adipose-derived stem cells (ADSCs) overexpressing miR-21 promote vascularization of endothelial cells. Sci Rep 91(9):1–10. https://doi.org/10.1038/s41598-019-49339-y
Antimisiaris SG, Mourtas S, Marazioti A (2018) Exosomes and exosome-inspired vesicles for targeted drug delivery. Pharmaceutics 10. https://doi.org/10.3390/PHARMACEUTICS10040218
Antonietta M, Bella D (2022) Overview and update on extracellular vesicles: considerations on exosomes and their application in modern medicine
Arifin DR, Witwer KW, Bulte JWM (2022) Non-invasive imaging of extracellular vesicles: quo vaditis in vivo? J Extracell Vesicles 11:12241. https://doi.org/10.1002/JEV2.12241
Ashique S, Anand K (2023) Radiolabelled extracellular vesicles as imaging modalities for precise targeted drug delivery. Pharm 15:1426. https://doi.org/10.3390/PHARMACEUTICS15051426
Azarmi M, Maleki H, Nikkam N, Malekinejad H (2020) Transcellular brain drug delivery: a review on recent. Int J Pharm 119582. https://doi.org/10.1016/j.ijpharm.2020.119582
Ballard C, Banister C, Khan Z et al (2018) Evaluation of the safety, tolerability, and efficacy of pimavanserin versus placebo in patients with Alzheimer’s disease psychosis: a phase 2, randomised, placebo-controlled, double-blind study. Lancet Neurol 17:213–222. https://doi.org/10.1016/S1474-4422(18)30039-5
Barbo M, Ravnik-Glavač M (2023) Extracellular vesicles as potential biomarkers in amyotrophic lateral sclerosis. Genes 14:325. https://doi.org/10.3390/GENES14020325
Bobis-Wozowicz S, Marbán E (2022) Editorial: extracellular vesicles as next generation therapeutics. Front Cell Dev Biol 10:919426. https://doi.org/10.3389/FCELL.2022.919426/BIBTEX
Cano A, Muñoz-Morales Á, Sánchez-López E et al (2023) Exosomes-based Nanomedicine for neurodegenerative diseases: current insights and future challenges. Pharmaceutics 15. https://doi.org/10.3390/PHARMACEUTICS15010298
Chen C, Skog J, Hsu CH et al (2010) Microfluidic isolation and transcriptome analysis of serum microvesicles. Lab Chip 10:505. https://doi.org/10.1039/B916199F
Choi SY, Han EC, Hong SH et al (2019) Regulating osteogenic differentiation by suppression of exosomal MicroRNAs. 25:1146–1154. https://doi.org/10.1089/TEN.TEA.2018.0257. https://home.liebertpub.com/tea
Choi H, Choi K, Kim D et al (2022) Strategies for targeted delivery of exosomes to the brain : advantages and challenges. Pharmaceutics 1–14. https://doi.org/10.3390/pharmaceutics14030672
Choudhari M, Hejmady S, Narayan Saha R et al (2021) Evolving new-age strategies to transport therapeutics across the blood-brain-barrier. Int J Pharm 599:120351. https://doi.org/10.1016/J.IJPHARM.2021.120351
Ciferri MC, Quarto R, Tasso R (2021) Extracellular vesicles as biomarkers and therapeutic tools: from pre-clinical to clinical applications. Biology (Basel) 10. https://doi.org/10.3390/BIOLOGY10050359
Compton C (2020) Cancer: the enemy from within. Springer International Publishing
Contreras-Naranjo JC, Wu HJ, Ugaz VM (2017) Microfluidics for exosome isolation and analysis: enabling liquid biopsy for personalized medicine. Lab Chip 17:3558–3577. https://doi.org/10.1039/C7LC00592J
Cruz MEM, Simões SID, Corvo ML et al (2009) Formulation of nanoparticulate drug delivery systems (NPDDS) for macromolecules. Informa Healthcare, New York
Cummings JL, Tong G, Ballard C (2019) Treatment combinations for Alzheimer’s disease: current and future pharmacotherapy options. J Alzheimer’s Dis 67:779–794. https://doi.org/10.3233/JAD-180766
Doyle LM, Wang MZ (2019) Isolation and. Analysis:29–39
Edelstein L, Smythies JR, Quesenberry PJ, et al (2019) Exosomes: a clinical compendium 550
Edmonds S, Volpe A, Shmeeda H et al (2016) Exploiting the metal-chelating properties of the drug cargo for in vivo positron emission tomography imaging of liposomal Nanomedicines. ACS Nano 10:10294–10307. https://doi.org/10.1021/ACSNANO.6B05935
Fu S, Wang Y, Xia X, Zheng JC (2020) NanoImpact exosome engineering: current progress in cargo loading and targeted delivery. NanoImpact 20:100261. https://doi.org/10.1016/j.impact.2020.100261
Fuhrmann G, Serio A, Mazo M et al (2015) Active loading into extracellular vesicles significantly improves the cellular uptake and photodynamic effect of porphyrins. J Control Release 205:35–44. https://doi.org/10.1016/J.JCONREL.2014.11.029
Galardi A, De Bethlen A, Di Paolo V et al (2023) Recent advancements on the use of exosomes as drug carriers for the treatment of glioblastoma. Life 13:964. https://doi.org/10.3390/LIFE13040964
Gangadaran P, Li XJ, Lee HW et al (2017) A new bioluminescent reporter system to study the biodistribution of systematically injected tumor-derived bioluminescent extracellular vesicles in mice. Oncotarget 8:109894–109914. https://doi.org/10.18632/ONCOTARGET.22493
Goyal D, Shuaib S, Mann S, Goyal B (2017) Rationally designed peptides and Peptidomimetics as inhibitors of amyloid-β (Aβ) aggregation: potential therapeutics of Alzheimer’s disease. ACS Comb Sci 19:55–80. https://doi.org/10.1021/ACSCOMBSCI.6B00116/ASSET/IMAGES/MEDIUM/CO-2016-00116T_0042.GIF
Gray WD, Mitchell AJ, Searles CD (2015) An accurate, precise method for general labeling of extracellular vesicles. MethodsX 2:360–367. https://doi.org/10.1016/j.mex.2015.08.002
Gurunathan S, Kang MH, Jeyaraj M et al (2019) Review of the isolation, characterization, biological function, and multifarious therapeutic approaches of exosomes. Cell 8. https://doi.org/10.3390/cells8040307
Gurung S, Perocheau D, Touramanidou L, Baruteau J (2021) The exosome journey: from biogenesis to uptake and intracellular signalling. Cell Commun Signal:1–19. https://doi.org/10.1186/s12964-021-00730-1
György B, Lööv C, Zaborowski MP et al (2018) CRISPR/Cas9 mediated disruption of the Swedish APP allele as a therapeutic approach for early-onset Alzheimer’s disease. Mol Ther Nucleic Acids 11:429. https://doi.org/10.1016/J.OMTN.2018.03.007
Haney MJ, Klyachko NL, Zhao Y et al (2015) Exosomes as drug delivery vehicles for Parkinson’s disease therapy. J Control Release 207:18. https://doi.org/10.1016/J.JCONREL.2015.03.033
Harrell CR, Volarevic A, Djonov V et al (2021) Mesenchymal stem cell-derived exosomes as new remedy for the treatment of neurocognitive disorders. Int J Mol Sci 22:1433. https://doi.org/10.3390/IJMS22031433
He W, Mei Q, Li J et al (2021) Preferential targeting cerebral ischemic lesions with cancer cell-inspired Nanovehicle for ischemic stroke treatment. Nano Lett 21:3033–3043. https://doi.org/10.1021/ACS.NANOLETT.1C00231/SUPPL_FILE/NL1C00231_SI_001.PDF
Herrmann IK, John M, Wood A, Fuhrmann G (2021) Delivery platform. Nat Nanotechnol 16. https://doi.org/10.1038/s41565-021-00931-2
Hoshino A, Costa-Silva B, Shen TL et al (2015) Tumour exosome integrins determine organotropic metastasis. Nature 5277578(527):329–335. https://doi.org/10.1038/nature15756
Huda MN, Nafiujjaman M, Deaguero IG et al (2021) Potential use of exosomes as diagnostic biomarkers and in targeted Drug Delivery: Progress in clinical and preclinical applications. ACS Biomater Sci Eng 7:2106–2149. https://doi.org/10.1021/ACSBIOMATERIALS.1C00217
Hwang DW (2019) Perspective in nuclear Theranostics using exosome for the brain. Nucl med Mol imaging (2010) 53:108. https://doi.org/10.1007/S13139-018-00567-6
Ibrahim AGE, Cheng K, Marbán E (2014) Exosomes as critical agents of cardiac regeneration triggered by cell therapy. Stem Cell Reports 2:606–619. https://doi.org/10.1016/J.STEMCR.2014.04.006
Izadpanah M, Seddigh A, Ebrahimi Barough S et al (2018) Potential of extracellular vesicles in neurodegenerative diseases: diagnostic and therapeutic indications. J Mol Neurosci 66:172–179. https://doi.org/10.1007/S12031-018-1135-X/METRICS
Jan AT, Malik MA, Rahman S et al (2017) Perspective insights of exosomes in neurodegenerative diseases: a critical appraisal. Front Aging Neurosci 9:277074. https://doi.org/10.3389/FNAGI.2017.00317/BIBTEX
Jang SC, Kim OY, Yoon CM et al (2013) Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors. ACS Nano 7:7698–7710. https://doi.org/10.1021/NN402232G/SUPPL_FILE/NN402232G_SI_001.PDF
Jeyaraman M, Muthu S, Gulati A et al (2021) Mesenchymal stem cell–derived exosomes: a potential therapeutic avenue in knee osteoarthritis. Cartilage 13:1572S–1585S. https://doi.org/10.1177/1947603520962567/ASSET/IMAGES/LARGE/10.1177_1947603520962567-FIG4.JPEG
Kanada M, Bachmann MH, Hardy JW et al (2015) Differential fates of biomolecules delivered to target cells via extracellular vesicles. Proc Natl Acad Sci U S A 112:E1433–E1442. https://doi.org/10.1073/PNAS.1418401112/-/DCSUPPLEMENTAL
Katakowski M, Chopp M (2016) Exosomes as tools to suppress primary brain tumor. Cell Mol Neurobiol 36:343–352. https://doi.org/10.1007/S10571-015-0280-9
Khan AA, De Rosales RTM (2021) Nanotheranostics radiolabelling of extracellular vesicles for PET and SPECT imaging:5. https://doi.org/10.7150/ntno.51676
Khatami SH, Karami N, Taheri-Anganeh M et al (2023) Exosomes: promising delivery tools for overcoming blood-brain barrier and glioblastoma therapy. Mol Neurobiol 60:1. https://doi.org/10.1007/S12035-023-03365-0
Kim MS, Haney MJ, Zhao Y et al (2016) Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells. Nanomed Nanotechnol Biol Med 12:655–664. https://doi.org/10.1016/J.NANO.2015.10.012
Kim MS, Haney MJ, Zhao Y et al (2018) Engineering macrophage-derived exosomes for targeted paclitaxel delivery to pulmonary metastases: in vitro and in vivo evaluations. Nanomed Nanotechnol Biol Med 14:195–204. https://doi.org/10.1016/J.NANO.2017.09.011
Kim G, Kim M, Lee Y et al (2019) Systemic delivery of microRNA-21 antisense oligonucleotides to the brain using T7-peptide decorated exosomes. J Control Release 317:273–281. https://doi.org/10.1016/J.JCONREL.2019.11.009
Kodam SP, Ullah M (2021) Diagnostic and therapeutic potential of extracellular vesicles. Technol Cancer Res Treat 20. https://doi.org/10.1177/15330338211041203/ASSET/IMAGES/LARGE/10.1177_15330338211041203-FIG1.JPEG
Lai RC, Arslan F, Lee MM et al (2010) Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res 4:214–222. https://doi.org/10.1016/J.SCR.2009.12.003
Lamichhane TN, Raiker RS, Jay SM (2015) Exogenous DNA loading into extracellular vesicles via electroporation is size-dependent and enables limited gene delivery. Mol Pharm 12:3650–3657. https://doi.org/10.1021/ACS.MOLPHARMACEUT.5B00364/SUPPL_FILE/MP5B00364_SI_001.PDF
Lázaro-Ibánez E, Al-Jamal KT, Dekker N et al (2021) Selection of fluorescent, bioluminescent, and radioactive tracers to accurately reflect extracellular vesicle biodistribution in vivo. ACS Nano 15:3212–3227. https://doi.org/10.1021/ACSNANO.0C09873/SUPPL_FILE/NN0C09873_SI_001.PDF
Lee YS, Yeo IJ, Kim KC et al (2019) Inhibition of lung tumor development in ApoE knockout mice via enhancement of TREM-1 dependent NK cell cytotoxicity. Front Immunol 10:430604. https://doi.org/10.3389/FIMMU.2019.01379/BIBTEX
Li I, Nabet BY (2019) Exosomes in the tumor microenvironment as mediators of cancer therapy resistance. Mol Cancer 18. https://doi.org/10.1186/S12943-019-0975-5
Li P, Kaslan M, Lee SH et al (2017) Progress in exosome isolation techniques theranostics. 7:789–804. https://doi.org/10.7150/THNO.18133
Li J, Xiao L, He D et al (2021a) Mechanism of white matter injury and promising therapeutic strategies of MSCs after intracerebral hemorrhage. Front Aging Neurosci 13:632054. https://doi.org/10.3389/FNAGI.2021.632054/BIBTEX
Li C, Sun T, Jiang C (2021b) Recent advances in nanomedicines for the treatment of ischemic stroke. Acta Pharm Sin B 11:1767–1788. https://doi.org/10.1016/J.APSB.2020.11.019
Li C, Qin S, Wen Y et al (2022a) Overcoming the blood-brain barrier: exosomes as theranostic nanocarriers for precision neuroimaging. J Control Release 349:902–916. https://doi.org/10.1016/J.JCONREL.2022.08.002
Li J, Li Y, Li P et al (2022b) Exosome detection via surface-enhanced Raman spectroscopy for cancer diagnosis. Acta Biomater 144:1–14. https://doi.org/10.1016/J.ACTBIO.2022.03.036
Liang G, Zhu Y, Ali DJ et al (2020) Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer. J Nanobiotechnology 18:1–15. https://doi.org/10.1186/S12951-019-0563-2/FIGURES/6
Liao W, Du Y, Zhang C et al (2019) Exosomes: the next generation of endogenous nanomaterials for advanced drug delivery and therapy. Acta Biomater 86:1–14. https://doi.org/10.1016/j.actbio.2018.12.045
Lingineni K, Belekar V, Tangadpalliwar SR, Garg P (2017) The role of multidrug resistance protein (MRP-1) as an active efflux transporter on blood-brain barrier (BBB) permeability. Mol Divers 21:355–365. https://doi.org/10.1007/S11030-016-9715-6
Liu H, Sun Y, Zhang Q et al (2021) Pro-inflammatory and proliferative microglia drive progression of glioblastoma. Cell Rep 36:109718. https://doi.org/10.1016/J.CELREP.2021.109718
Livshts MA, Khomyakova E, Evtushenko EG et al (2015) Isolation of exosomes by differential centrifugation: theoretical analysis of a commonly used protocol. Sci Rep 51(5):1–14. https://doi.org/10.1038/srep17319
Lou G, Song X, Yang F et al (2015) Exosomes derived from MIR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma. J Hematol Oncol 8:1–11. https://doi.org/10.1186/S13045-015-0220-7/FIGURES/6
Lu YC, Chu T, Hall MS et al (2019) Physical confinement induces malignant transformation in mammary epithelial cells. Biomaterials 217:119307. https://doi.org/10.1016/J.BIOMATERIALS.2019.119307
Luan X, Sansanaphongpricha K, Myers I et al (2017) Engineering exosomes as refined biological nanoplatforms for drug delivery. Nat Publ Gr 38:754–763. https://doi.org/10.1038/aps.2017.12
Malla RR, Pandrangi S, Kumari S et al (2018) Exosomal tetraspanins as regulators of cancer progression and metastasis and novel diagnostic markers. Asia Pac J Clin Oncol 14:383–391. https://doi.org/10.1111/AJCO.12869
Man F, Gawne PJ, de Rosales RTM (2019) Nuclear imaging of liposomal drug delivery systems: a critical review of radiolabelling methods and applications in nanomedicine. Adv Drug Deliv Rev 143:134–160. https://doi.org/10.1016/J.ADDR.2019.05.012
Mehryab F, Rabbani S, Shahhosseini S et al (2020) Exosomes as a next-generation drug delivery system: an update on drug loading approaches, characterization, and clinical application challenges. Acta Biomater. https://doi.org/10.1016/j.actbio.2020.06.036
Meyer C, Losacco J, Stickney Z et al (2017) Pseudotyping exosomes for enhanced protein delivery in mammalian cells. Int J Nanomedicine 12:3153–3170. https://doi.org/10.2147/IJN.S133430
Michinaga S, Koyama Y (2021) Pathophysiological responses and roles of astrocytes in traumatic brain injury. Int J Mol Sci 22:22. https://doi.org/10.3390/IJMS22126418
Mirzaei H, Rahimian N, Mirzaei HR et al (2022) Exosomes and microRNAs in biomedical science. Springer International Publishing, Cham
Molino Y, David M, Varini K et al (2017) Use of LDL receptor-targeting peptide vectors for in vitro and in vivo cargo transport across the blood-brain barrier. FASEB J 31:1807–1827. https://doi.org/10.1096/FJ.201600827R
Morishita M, Takahashi Y, Nishikawa M et al (2015a) Quantitative analysis of tissue distribution of the B16BL6-derived exosomes using a streptavidin – Lactadherin fusion protein and Iodine-125-labeled biotin derivative after intravenous:705–713. https://doi.org/10.1002/jps.24251
Morishita M, Takahashi Y, Nishikawa M et al (2015b) Quantitative analysis of tissue distribution of the B16BL6-derived exosomes using a streptavidin-lactadherin fusion protein and Iodine-125-labeled biotin derivative after intravenous injection in mice. J Pharm Sci 104:705–713. https://doi.org/10.1002/jps.24251
Nasiri A, Cheng L, Hill AF (2023) Methods for loading therapeutics into extracellular vesicles and generating extracellular vesicles mimetic-nanovesicles. Methods 177:103–113. https://doi.org/10.1016/j.ymeth.2020.01.001
Nie D, Dai Z, Li J et al (2020) Cancer-cell-membrane-coated nanoparticles with a yolk-Shell structure augment cancer chemotherapy. Nano Lett 20:936–946. https://doi.org/10.1021/ACS.NANOLETT.9B03817/SUPPL_FILE/NL9B03817_SI_001.PDF
Ouerdane Y, Hassaballah MY, Nagah A et al (2022) Exosomes in Parkinson: revisiting their pathologic role and potential applications. Pharmaceuticals 15. https://doi.org/10.3390/PH15010076
Panzarini E, Mariano S, Tacconi S et al (2021) Novel therapeutic delivery of Nanocurcumin in central nervous system related disorders. Nano 11:1–30. https://doi.org/10.3390/NANO11010002
Patil SM, Sawant SS, Kunda NK (2020) Exosomes as drug delivery systems: a brief overview and progress update. Eur J Pharm Biopharm 154:259–269. https://doi.org/10.1016/J.EJPB.2020.07.026
Pellico J, Gawne PJ, De Rosales RTM (2021) Chem Soc Rev Imag Ther:3355–3423. https://doi.org/10.1039/d0cs00384k
Persano F, Gigli G, Leporatti S (2022) Natural compounds as promising adjuvant agents in the treatment of gliomas. Int J Mol Sci 23:3360. https://doi.org/10.3390/IJMS23063360
Peterson MF, Otoc N, Sethi JK et al (2015) Integrated systems for exosome investigation. Methods 87:31–45. https://doi.org/10.1016/J.YMETH.2015.04.015
Phillips WT, Rudolph AS, Goins B et al (1992) A simple method for producing a technetium-99m-labeled liposome which is stable in vivo. Int J Radiat Appl Instrument Part B Nucl Med Biol 19:539–547. https://doi.org/10.1016/0883-2897(92)90149-S
Phua VJX, Yang CT, Xia B et al (2022) Nanomaterial probes for nuclear imaging. Nano 12. https://doi.org/10.3390/NANO12040582
Pinheiro RGR, Coutinho AJ, Pinheiro M (2021) Nanoparticles for targeted brain drug delivery: what do we know ?
Rayamajhi S, Aryal S (2020) Surface functionalization strategies of extracellular vesicles. J Mater Chem B 8:4552–4569. https://doi.org/10.1039/D0TB00744G
Reardon DA, Brandes AA, Omuro A et al (2020) Effect of Nivolumab vs bevacizumab in patients with recurrent glioblastoma: the CheckMate 143 phase 3 randomized clinical trial. JAMA Oncol 6:1. https://doi.org/10.1001/JAMAONCOL.2020.1024
Royo F, Cossío U, De Angulo AR et al (2019) Nanoscale vesicles alters their biodistribution in mice †:1531–1537. https://doi.org/10.1039/c8nr03900c
Sabapatha A, Gercel-taylor C, Taylor DD (2006) Specific isolation of placenta-derived exosomes from the circulation of pregnant women and their Immunoregulatory Consequences1. Am J Reprod Immunol 56:345–355. https://doi.org/10.1111/J.1600-0897.2006.00435.X
Salarpour S, Forootanfar H, Pournamdari M et al (2019) Paclitaxel incorporated exosomes derived from glioblastoma cells: comparative study of two loading techniques. DARU J Pharm Sci 27:533. https://doi.org/10.1007/S40199-019-00280-5
Sancho-Albero M, Encabo-Berzosa MDM, Beltrán-Visiedo M et al (2019) Efficient encapsulation of theranostic nanoparticles in cell-derived exosomes: leveraging the exosomal biogenesis pathway to obtain hollow gold nanoparticle-hybrids. Nanoscale 11:18825–18836. https://doi.org/10.1039/C9NR06183E
Saver JL, Goyal M, Van Der Lugt A et al (2016) Time to treatment with endovascular Thrombectomy and outcomes from ischemic stroke: a meta-analysis. JAMA 316:1279–1288. https://doi.org/10.1001/JAMA.2016.13647
Sciences P, Mvbs S (2021) Drug loading techniques for exosome-based drug delivery systems. 76:61–67
Shao H, Im H, Castro CM et al (2018) New technologies for analysis of extracellular vesicles. https://doi.org/10.1021/acs.chemrev.7b00534
Shi M, Liu C, Cook TJ et al (2014) Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson’s disease. Acta Neuropathol 128:639. https://doi.org/10.1007/S00401-014-1314-Y
Sims RR, Bendifallah I, Blanchard K et al (2023) Optical manipulation and recording of neural activity with Wavefront engineering. NeuroMethods 191:1–48. https://doi.org/10.1007/978-1-0716-2764-8_1/FIGURES/4
Smyth T, Petrova K, Payton NM et al (2014) Surface functionalization of exosomes using click chemistry. Bioconjug Chem 25:1777–1784. https://doi.org/10.1021/BC500291R/SUPPL_FILE/BC500291R_SI_001.PDF
Song J, Lu C, Leszek J, Zhang J (2021) Design and development of nanomaterial-based drug carriers to overcome the blood – brain barrier by using different transport mechanisms
Strohmeier K, Hofmann M, Hauser F et al (2022) Crispr/cas9 genome editing vs. over-expression for fluorescent extracellular vesicle-labeling: a quantitative analysis. Int J Mol Sci 23:282. https://doi.org/10.3390/IJMS23010282/S1
Sun J, Zhang Z, Ma T et al (2018) Endothelial progenitor cell-derived exosomes, loaded with miR-126, promoted deep vein thrombosis resolution and recanalization. Stem Cell Res Ther 9. https://doi.org/10.1186/S13287-018-0952-8
Sun Y, Ren D, Yang C et al (2021) TRIM15 promotes the invasion and metastasis of pancreatic cancer cells by mediating APOA1 ubiquitination and degradation. Biochim Biophys Acta Mol basis Dis 1867:166213. https://doi.org/10.1016/J.BBADIS.2021.166213
Szatanek R, Baj-Krzyworzeka M, Zimoch J et al (2017) The methods of choice for extracellular vesicles (EVs) characterization. Int J Mol Sci 18. https://doi.org/10.3390/IJMS18061153
Tauro BJ, Greening DW, Mathias RA et al (2012) Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes. Methods 56:293–304. https://doi.org/10.1016/J.YMETH.2012.01.002
Teleanu RI, Preda MD, Niculescu AG et al (2022) Current strategies to enhance delivery of drugs across the blood–brain barrier. Pharm 14:987. https://doi.org/10.3390/PHARMACEUTICS14050987
Terriaca S, Fiorelli E, Scioli MG et al (2021) Endothelial progenitor cell-derived extracellular vesicles: potential therapeutic application in tissue repair and regeneration. Int J Mol Sci 22. https://doi.org/10.3390/IJMS22126375
Tian Y, Li S, Song J et al (2014) A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. Biomaterials 35:2383–2390. https://doi.org/10.1016/J.BIOMATERIALS.2013.11.083
Van Der Pol E, Bo AN (2012) Classification, functions, and clinical relevance of extracellular vesicles. 64:676–705
Van Deun J, Mestdagh P, Sormunen R et al (2014) The impact of disparate isolation methods for extracellular vesicles on downstream RNA profiling. J Extracell Vesicles 3. https://doi.org/10.3402/JEV.V3.24858
Wang Z, Wu HJ, Fine D et al (2013) Ciliated micropillars for the microfluidic-based isolation of nanoscale lipid vesicles. Lab Chip 13:2879–2882. https://doi.org/10.1039/C3LC41343H
Wang J, Chen D, Ho EA (2020) Challenges in the development and establishment of exosome-based drug delivery systems. J Control Release. https://doi.org/10.1016/j.jconrel.2020.10.020
Wang J, Chen D, Ho EA (2021) Challenges in the development and establishment of exosome-based drug delivery systems. J Control Release 329:894–906. https://doi.org/10.1016/J.JCONREL.2020.10.020
Wang J, Liu Y, Morsch M et al (2022) Brain-targeted aggregation-induced-emission nanoparticles with near-infrared imaging at 1550 nm boosts Orthotopic glioblastoma Theranostics. Adv Mater 34. https://doi.org/10.1002/ADMA.202106082
Wang H, Guan LP, Deng M (2023) Recent progress of the genetics of amyotrophic lateral sclerosis and challenges of gene therapy. Front Neurosci 17:1170996. https://doi.org/10.3389/FNINS.2023.1170996/BIBTEX
Weng S, Lai QL, Wang J et al (2022) The role of exosomes as mediators of Neuroinflammation in the pathogenesis and treatment of Alzheimer’s disease. Front Aging Neurosci 14:899944. https://doi.org/10.3389/FNAGI.2022.899944/BIBTEX
Witwer KW, Buzás EI, Bemis LT et al (2013) Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. https://doi.org/10.3402/JEV.V2I0.20360
Witwer KW, Goberdhan DCI, O’Driscoll L et al (2021) Updating MISEV: evolving the minimal requirements for studies of extracellular vesicles. J Extracell Vesicles 10. https://doi.org/10.1002/JEV2.12182
Wood MJA, O’Loughlin AJ, Lakhal S (2011) Exosomes and the blood-brain barrier: implications for neurological diseases. Ther Deliv 2:1095–1099. https://doi.org/10.4155/TDE.11.83
Xiao J, Cretoiu S (2017) Exosomes in cardiovascular diseases:998. https://doi.org/10.1007/978-981-10-4397-0
Yáñez-mó M, Siljander PR, Andreu Z et al (2015) Biological properties of extracellular vesicles and their physiological functions. 3078. https://doi.org/10.3402/jev.v4.27066
Yang C, Kim SH, Bianco NR, Robbins PD (2011) Tumor-derived exosomes confer antigen-specific immunosuppression in a murine delayed-type hypersensitivity model. PLoS One 6. https://doi.org/10.1371/JOURNAL.PONE.0022517
Yong T, Zhang X, Bie N et al (2019) Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy. Nat Commun 101(10):1–16. https://doi.org/10.1038/s41467-019-11718-4
Zarovni N, Corrado A, Guazzi P et al (2015) Integrated isolation and quantitative analysis of exosome shuttled proteins and nucleic acids using immunocapture approaches. Methods 87:46–58. https://doi.org/10.1016/J.YMETH.2015.05.028
Zeng H, Guo S, Ren X et al (2023) Current strategies for exosome cargo loading and targeting delivery. Cell 12. https://doi.org/10.3390/CELLS12101416
Zeringer E, Barta T, Li M, Vlassov AV (2015) Strategies for isolation of exosomes. Cold Spring Harb Protoc 2015:319–323. https://doi.org/10.1101/PDB.TOP074476
Zhang K, Cheng K (2023) Stem cell-derived exosome versus stem cell therapy. Nat Rev Bioeng 2023:1–2. https://doi.org/10.1038/s44222-023-00064-2
Zhang Y, Chopp M, Liu XS et al (2017) Exosomes derived from mesenchymal stromal cells promote axonal growth of cortical neurons. Mol Neurobiol 54:2659. https://doi.org/10.1007/S12035-016-9851-0
Zhang M, Jin K, Gao L et al (2018) Methods and technologies for exosome isolation and characterization. Small Methods 2:1–10. https://doi.org/10.1002/smtd.201800021
Zhang Y, Li Y, Li T et al (2019) Genetic load and potential mutational meltdown in cancer cell populations. Mol Biol Evol 36:541–552. https://doi.org/10.1093/MOLBEV/MSY231
Zhang Y, Bi J, Huang J et al (2020) Exosome: a review of its classification, isolation techniques, storage, diagnostic and targeted therapy applications. Int J Nanomedicine 15:6917–6934. https://doi.org/10.2147/IJN.S264498
Zhang H, Yan C, Wang Y (2021) Exosome-mediated transfer of circHIPK3 promotes trastuzumab chemoresistance in breast cancer. J Drug Target 29:1004–1015. https://doi.org/10.1080/1061186X.2021.1906882/SUPPL_FILE/IDRT_A_1906882_SM6134.TIF
Zhang Y, Bi J, Huang J et al (2023) Exosome: a review of its classification, isolation techniques, storage, diagnostic and targeted therapy applications. https://doi.org/10.2147/IJN.S264498
Zhao LR, Zhang JH (2015) Cellular therapy for stroke and CNS injuries. Springer International Publishing
Zheng L, Zhang B, Chu H et al (2020) Assembly and in vitro assessment of a powerful combination: aptamer-modified exosomes combined with gold nanorods for effective photothermal therapy. Nanotechnology 31:485101. https://doi.org/10.1088/1361-6528/ABB0B8
Zhou X, Xie F, Wang L et al (2020a) The function and clinical application of extracellular vesicles in innate immune regulation. Cell Mol Immunol. https://doi.org/10.1038/s41423-020-0391-1
Zhou B, Xu K, Zheng X et al (2020b) Application of exosomes as liquid biopsy in clinical diagnosis. Signal Transduct Target Ther 51(5):1–14. https://doi.org/10.1038/s41392-020-00258-9
Zhu ZH, Jia F, Ahmed W et al (2023) Neural stem cell-derived exosome as a nano-sized carrier for BDNF delivery to a rat model of ischemic stroke. Neural Regen Res 18:404. https://doi.org/10.4103/1673-5374.346466
Zülke AE, Riedel-Heller SG, Wittmann F et al (2023) Gender-specific design and effectiveness of non-pharmacological interventions against cognitive decline — systematic review and meta-analysis of randomized controlled trials. J Prev Alzheimers Dis 10:69–82. https://doi.org/10.14283/JPAD.2022.80/FIGURES/4
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2024 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Uddin, M.J., Faiyazuddin, M., Hassan, J., Sadiq, S.B., Khan, S.I., Nawar, A. (2024). Advancement of Radiolabeled Exosomes in Brain Disorders. In: Mishra, N., Ashique, S., Garg, A., Chithravel, V., Anand, K. (eds) Exosomes Based Drug Delivery Strategies for Brain Disorders. Springer, Singapore. https://doi.org/10.1007/978-981-99-8373-5_13
Download citation
DOI: https://doi.org/10.1007/978-981-99-8373-5_13
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-8372-8
Online ISBN: 978-981-99-8373-5
eBook Packages: MedicineMedicine (R0)